EXPLORE CONNECTIONS
Distinct tumor-immune ecologies in NSCLC patientspredict progression and define a clinical biomarker of therapy response
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.